X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (6013) 6013
humans (4782) 4782
female (3612) 3612
animals (3392) 3392
middle aged (3362) 3362
stroke (2908) 2908
aged (2798) 2798
neurosciences (2634) 2634
clinical neurology (2502) 2502
rats (2194) 2194
infarction, middle cerebral artery - physiopathology (1924) 1924
brain ischemia - physiopathology (1677) 1677
adult (1549) 1549
disease models, animal (1489) 1489
ischemia (1450) 1450
cerebral infarction - physiopathology (1445) 1445
stroke - physiopathology (1343) 1343
time factors (1253) 1253
brain (1223) 1223
peripheral vascular disease (1217) 1217
magnetic resonance imaging (1194) 1194
rats, sprague-dawley (1161) 1161
neurology (1106) 1106
risk factors (1074) 1074
aged, 80 and over (1067) 1067
infarction (1020) 1020
brain - pathology (969) 969
treatment outcome (913) 913
infarction, middle cerebral artery - pathology (885) 885
brain - physiopathology (879) 879
mice (802) 802
cerebrovascular circulation (753) 753
cerebral ischemia (730) 730
cerebral infarction (713) 713
cerebral infarction - pathology (708) 708
brain ischemia - pathology (694) 694
prognosis (641) 641
tomography, x-ray computed (607) 607
surgery (605) 605
cerebrovascular circulation - physiology (585) 585
retrospective studies (578) 578
artery occlusion (575) 575
brain - blood supply (567) 567
rats, wistar (559) 559
ischemic attack, transient - physiopathology (537) 537
prospective studies (536) 536
reperfusion (523) 523
infarction, middle cerebral artery - complications (519) 519
neuroprotection (513) 513
infarction, middle cerebral artery - drug therapy (496) 496
cerebral blood flow (493) 493
blood-flow (488) 488
cardiac & cardiovascular systems (484) 484
predictive value of tests (481) 481
analysis (477) 477
mortality (445) 445
stroke - pathology (445) 445
rat (442) 442
myocardial-infarction (437) 437
severity of illness index (433) 433
research (426) 426
brain infarction - physiopathology (421) 421
mice, inbred c57bl (420) 420
brain - metabolism (417) 417
infarction, middle cerebral artery - metabolism (416) 416
neuroprotective agents - pharmacology (415) 415
cerebral-artery occlusion (412) 412
occlusion (412) 412
brain ischemia - drug therapy (410) 410
injury (404) 404
follow-up studies (400) 400
expression (396) 396
hypertension (388) 388
cerebral infarction - etiology (387) 387
brain - drug effects (381) 381
medicine & public health (380) 380
middle cerebral artery occlusion (375) 375
ischemic stroke (371) 371
cardiovascular diseases (369) 369
endocrinology & metabolism (368) 368
disease (366) 366
blood pressure (364) 364
care and treatment (362) 362
hematology (352) 352
brain ischemia - complications (350) 350
neurons (347) 347
brain ischemia - metabolism (343) 343
cerebral arteries - physiopathology (343) 343
reperfusion injury - physiopathology (343) 343
stroke - etiology (342) 342
acute ischemic-stroke (341) 341
apoptosis (340) 340
risk (337) 337
focal cerebral-ischemia (334) 334
acute disease (331) 331
focal ischemia (328) 328
cerebral cortex - physiopathology (327) 327
stroke - complications (326) 326
cerebrovascular circulation - drug effects (318) 318
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7522) 7522
Japanese (120) 120
Chinese (69) 69
Russian (32) 32
German (31) 31
French (29) 29
Spanish (27) 27
Polish (8) 8
Portuguese (4) 4
Hungarian (2) 2
Bulgarian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 2016, Volume 373, pp. 201 - 207
...–middle cerebral artery (MCA) anastomosis operation in patients with internal carotid artery (ICA) or MCA occlusion... 
Neurology | Cognition | Cerebral blood flow | SPECT | STA-MCA anastomosis | STENO-OCCLUSIVE DISEASE | CAROTID-ENDARTERECTOMY | BYPASS-SURGERY | BLOOD-FLOW | NEUROSCIENCES | CLINICAL NEUROLOGY | TRIAL | HEMODYNAMIC CEREBRAL-ISCHEMIA | ARTERY | SPEC | Infarction, Middle Cerebral Artery - physiopathology | Humans | Temporal Arteries - diagnostic imaging | Tomography, Emission-Computed, Single-Photon | Male | Temporal Arteries - physiopathology | Recovery of Function | Infarction, Middle Cerebral Artery - complications | Infarction, Middle Cerebral Artery - psychology | Middle Cerebral Artery - physiopathology | Cognition - physiology | Temporal Arteries - surgery | Female | Cognitive Dysfunction - diagnostic imaging | Carotid Stenosis - surgery | Cognitive Dysfunction - surgery | Cerebral Revascularization | Middle Cerebral Artery - diagnostic imaging | Middle Cerebral Artery - surgery | Carotid Stenosis - psychology | Carotid Stenosis - physiopathology | Linear Models | Treatment Outcome | Cerebrovascular Circulation | Cognitive Dysfunction - etiology | Cognitive Dysfunction - physiopathology | Carotid Stenosis - complications | Neuropsychological Tests | Carotid Artery, Internal - diagnostic imaging | Carotid Artery, Internal - physiopathology | Infarction, Middle Cerebral Artery - surgery | Anastomosis, Surgical | Aged | Nervous system | Surgery | SPECT imaging
Journal Article
Stroke (1970), ISSN 1524-4628, 2007, Volume 38, Issue 8, pp. 2309 - 2314
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 12/2008, Volume 295, Issue 6, pp. 2455 - 2465
.... The present study examined whether elevated production of 20-HETE in the cerebral vasculature could contribute to the larger infarct size previously reported after transient middle cerebral artery occlusion (MCAO... 
N-hydroxy-N′-(4-butyl-2-methylphenyl)-formamidine | 20-hydroxyeicosatetraenoic acid | Middle cerebral artery occlusion | Cytochrome P-450A | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | ARTERY OCCLUSION | ENDOTHELIAL DYSFUNCTION | N-hydroxy-N '-(4-butyl-2-methylphenyl)-formamidine | PRONE | ARACHIDONIC-ACID | MODEL | BLOOD-FLOW | DELAYED VASOSPASM | SMOOTH-MUSCLE | cytochrome P-450A | COLLATERAL VESSELS | INHIBITION | PERIPHERAL VASCULAR DISEASE | middle cerebral artery occlusion | Blood Pressure | Infarction, Middle Cerebral Artery - physiopathology | Up-Regulation | Reactive Oxygen Species - metabolism | Oxidative Stress | Rats, Inbred WKY | Male | Infarction, Middle Cerebral Artery - metabolism | Stroke - physiopathology | Cerebral Arteries - drug effects | Stroke - pathology | Time Factors | Infarction, Middle Cerebral Artery - complications | Isoenzymes - metabolism | Disease Models, Animal | Rats, Inbred SHR | Severity of Illness Index | Stroke - prevention & control | Cerebrovascular Circulation - drug effects | Cytochrome P-450 CYP4A - metabolism | Enzyme Inhibitors - pharmacology | Rats | Cerebral Arteries - physiopathology | Infarction, Middle Cerebral Artery - pathology | Hypertension - pathology | Hypertension - physiopathology | Hypertension - metabolism | Hydroxyeicosatetraenoic Acids - metabolism | Stroke - etiology | Stroke - metabolism | Animals | Cerebral Arteries - metabolism | Cerebral Arteries - pathology | Hypertension - complications | Amidines - pharmacology | N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 7, p. e66960
...: Platelet adhesion and thrombus formation after endothelial injury was monitored in the carotid artery by intravital fluorescence microscopy... 
ADHESION | COLLAGEN | TISSUE-PLASMINOGEN ACTIVATOR | MULTIDISCIPLINARY SCIENCES | IN-VIVO | PLATELET GLYCOPROTEIN-VI | SOLUBLE GPVI | MICE | VON-WILLEBRAND-FACTOR | ISCHEMIC-STROKE | ANTITHROMBOTIC PROTECTION | Blood Platelets - pathology | Cerebral Infarction - drug therapy | Infarction, Middle Cerebral Artery - physiopathology | Inflammation - pathology | Recombinant Fusion Proteins - pharmacology | Recovery of Function - drug effects | Thrombosis - complications | Humans | Recombinant Fusion Proteins - therapeutic use | Stroke - complications | Glycoproteins - pharmacology | Venous Thrombosis - complications | Stroke - physiopathology | Stroke - pathology | Cerebral Infarction - physiopathology | Infarction, Middle Cerebral Artery - complications | Protein Binding - drug effects | Immunoglobulin Fc Fragments - therapeutic use | Infarction, Middle Cerebral Artery - drug therapy | Reperfusion Injury - complications | Blood Platelets - drug effects | Cerebral Infarction - pathology | Disease Models, Animal | von Willebrand Factor - metabolism | Thrombosis - physiopathology | Reperfusion Injury - pathology | Venous Thrombosis - drug therapy | Glycoproteins - therapeutic use | Treatment Outcome | Venous Thrombosis - physiopathology | Stroke - drug therapy | Infarction, Middle Cerebral Artery - pathology | Binding, Competitive - drug effects | Collagen - metabolism | Thrombosis - pathology | Animals | Cell Communication - drug effects | Immunoglobulin Fc Fragments - pharmacology | Reperfusion Injury - physiopathology | Mice | Venous Thrombosis - pathology | Endothelial Cells - pathology | Endothelial Cells - drug effects | Ischemia | Thrombosis | Collagen | Fluorescence microscopy | Heart attack | Blood clot | Myocardial infarction | Occlusion | Drugs | Fluorescence | Carotid arteries | Bleeding | Proteins | Reperfusion | Blood platelets | Cerebral blood flow | Rodents | Carotid artery | Fusion protein | Injuries | Cerebral infarction | Edema | Stroke | Immunoglobulins | Complications | Glycoprotein VI | Glycoproteins | Adhesion | Blood clots | Endothelium | Fc receptors | Infarction | Platelets | Veins & arteries
Journal Article
American journal of physiology. Heart and circulatory physiology, ISSN 1522-1539, 2014, Volume 307, Issue 5, pp. H658 - H669
... might play a role in the remodeling process. We hypothesized that TNF-α inhibition would improve middle cerebral artery (MCA... 
Hypertension | Cerebral vascular remodeling | Ischemic stroke | Tumor necrosis factor-α | Macrophages/microglia | RHEUMATOID-ARTHRITIS | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | ENDOTHELIAL DYSFUNCTION | BRAIN-INJURY | RECEPTOR | ANGIOTENSIN-II | MICE LACKING | cerebral vascular remodeling | tumor necrosis factor-alpha | STROKE-PRONE RATS | MEDIATED DILATIONS | PERIPHERAL VASCULAR DISEASE | TNF-ALPHA | hypertension | MICROVASCULAR FUNCTION | ischemic stroke | macrophages/microglia | Blood Pressure | Rats, Inbred SHR | Tumor Necrosis Factor-alpha - metabolism | Infarction, Middle Cerebral Artery - physiopathology | Microglia - metabolism | Immunoglobulin G - therapeutic use | Middle Cerebral Artery - drug effects | Rats | Hypertension - drug therapy | Male | Middle Cerebral Artery - pathology | Infarction, Middle Cerebral Artery - pathology | Vasodilation | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Immunoglobulin G - adverse effects | Receptors, Tumor Necrosis Factor - therapeutic use | Macrophages - metabolism | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Etanercept | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Middle Cerebral Artery - physiopathology | Immunoglobulin G - pharmacology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Vascular Biology and Microcirculation | macrophages | tumor necrosis factor-α | microglia
Journal Article
Journal Article
CNS Neuroscience & Therapeutics, ISSN 1755-5930, 04/2016, Volume 22, Issue 4, pp. 316 - 324
Summary Objectives Dynamically observe cerebral vascular changes in hyperglycemic rats... 
Hyperglycemia | Vascular dysfunction | Ischemia | Synchrotron radiation | Fasudil | DEPENDENT DILATATION | RHO-KINASE INHIBITION | NITRIC-OXIDE SYNTHASE | BLOOD-FLOW | NEUROSCIENCES | TYPE-1 DIABETIC-RATS | IN-VIVO | CARDIOVASCULAR-DISEASE | PHARMACOLOGY & PHARMACY | MYOGENIC TONE | ARTERIOLES | Infarction, Middle Cerebral Artery - physiopathology | Brain - diagnostic imaging | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Endothelium, Vascular - drug effects | Cerebral Hemorrhage - physiopathology | Endothelium, Vascular - physiology | Cerebral Arteries - drug effects | Neuroprotective Agents - pharmacology | Hyperglycemia - pathology | Infarction, Middle Cerebral Artery - drug therapy | Hyperglycemia - physiopathology | Diabetes Mellitus, Experimental - physiopathology | Cerebral Hemorrhage - drug therapy | Vasodilator Agents - pharmacology | Cerebral Arteries - diagnostic imaging | Brain - physiopathology | NG-Nitroarginine Methyl Ester | Organ Size | Cerebral Arteries - physiopathology | Infarction, Middle Cerebral Artery - pathology | Rats, Sprague-Dawley | Brain - drug effects | Animals | Cerebral Angiography | Endothelium, Vascular - diagnostic imaging | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | Cerebral Arteries - pathology | Brain - pathology | Diabetes Mellitus, Experimental - pathology | Endothelium, Vascular - pathology | Cerebral Hemorrhage - pathology | Stroke (Disease) | Particle accelerators | Streptozocin | Type 1 diabetes | Radiation | Endothelium
Journal Article